PA Excel: a division of hancock medical solutions
PA Excel: a division of hancock medical solutions
  • Home
  • Login
  • Contact
  • About us
  • PANCE PANRE PREP
  • Live PANCE Review
  • PANCE PANRE Review team
  • Virtual Rotation
  • Clinical Rotations
  • Prepared classes
  • PA Specialists
  • Clinical Year Assistance
  • International Education
  • PA Student resources
  • PA Financial Planning
  • Career counseling
  • PA Program organization
  • PANCE Notes Pages
  • Free PA Student Resourses
  • HELP Campus Runthrough
  • VROD Payment Portal
  • PA Prep Academy Payment P
  • More
    • Home
    • Login
    • Contact
    • About us
    • PANCE PANRE PREP
    • Live PANCE Review
    • PANCE PANRE Review team
    • Virtual Rotation
    • Clinical Rotations
    • Prepared classes
    • PA Specialists
    • Clinical Year Assistance
    • International Education
    • PA Student resources
    • PA Financial Planning
    • Career counseling
    • PA Program organization
    • PANCE Notes Pages
    • Free PA Student Resourses
    • HELP Campus Runthrough
    • VROD Payment Portal
    • PA Prep Academy Payment P
  • Home
  • Login
  • Contact
  • About us
  • PANCE PANRE PREP
  • Live PANCE Review
  • PANCE PANRE Review team
  • Virtual Rotation
  • Clinical Rotations
  • Prepared classes
  • PA Specialists
  • Clinical Year Assistance
  • International Education
  • PA Student resources
  • PA Financial Planning
  • Career counseling
  • PA Program organization
  • PANCE Notes Pages
  • Free PA Student Resourses
  • HELP Campus Runthrough
  • VROD Payment Portal
  • PA Prep Academy Payment P

internal/icu Case

CASES ARE UPDATED BY 11:00 AM. Please review the information below after 11:00 AM.

Please review the case below.  Use the information to write a COMPLETE SOAP note based on this information including a full treatment plan and orders you want to give.  EMAIL your note to virtual@paexcel.com


JOIN THE WEBINAR AT 6 PM FOR CASE REVIEW


 Your note should account for every Problem PLUS any new problems in the HPI, labs, xrays etc. as well as ALL medications. Please look up any medications you are not familiar with.   


When writing your plan, please use this template:

Diagnosis/Assessment:

  • Current Status of the disorder (better, worse?)
  • Reason (why did this happen?)
  • Recent review (what has recently been done? how did the pt respond to this action?)
  • Action (what are you doing about this today?)
  • Follow up 

EXAMPLE:

Hypertension:

  • Compensated, at goal
  • Reactive due to IV steroids
  • Responding to PRN hydralazine which was started 3 days ago
  • Monitor closely, will be decreasing Solumedrol as PNA is improving
  • Monitor BP closely with expectation of improvement with decreased Solumedrol

DID you miss this weeks webinar?

 Check out this recording of the most recent webinar.  Password is PAEXCELINTERNAL7 


Videos will be updated by 1 PM of the next day

HOW TO JOIN THE ZOOM WEBINAR at 6 PM

Please visit  https://zoom.us/join or download the ZOOM app.

Enter meeting ID: 941 3054 3374 

Password: 759101   

If the link is not working please follow these steps:

1: Refresh your browser, your cache may have saved last week's ID

2: Email jhancock@paexcel.com or call 754-300-7309 a staff member is standing by.

HERE IS YOUR CASE FOR TODAY

Please note all identifying data has been removed or changed to maintain HIPPA compliance.


HISTORY OF PRESENT ILLNESS

HPI:

78-year-old male admitted to Step down ICU from previous hospital where he had multiple presentations to the ER and admissions from 3/8/2020 until 5/8/2020 for acute pancytopenia, urinary retention with TURP, shortness of breath, cough and dark stools. Past medical history of COPD, current smoker with 40 pack year history, type 2 diabetes, diastolic heart failure. On 3/8/2020 he presented to the ER with weakness and was found to have hemoglobin of 4 requiring extensive blood transfusions and hematology workup. He initially refused GI workup and on 03/10 subsequent CT of the abdomen and pelvis resulted bladder mass lesion. He also underwent bone marrow biopsy on 03/11/2020 which revealed myelodysplastic syndrome. Patient was discharged home on 03/12/2020. He returned back to the hospital on 03/19/2020 for hematuria and acute urinary retention. He had a TURP done and tolerated procedure well and Foley catheter was left in place. He was sent home on 03/21/2020 with home health care to follow up with GU outpatient. Patient returned back to the hospital on 03/27/2020 for acute respiratory distress secondary to COPD exacerbation and was found with bilateral pneumonia and melena. He was found again to have a low hemoglobin on presentation of 3.2 and platelet count of 17000 and received again blood and platelet transfusions. He was stabilized in the ICU with intubation and was extubated on 04/18. This hospitalization was complicated by encephalopathy both anoxic and metabolic, with multiple blood transfusions and platelet transfusions secondary to myelodysplastic syndrome, stage III sacral wound, paroxysmal atrial fibrillation, oral dysphagia acute kidney injury. He had an upper endoscopy done by GI and no bleeding was found. GI recommended acid suppression and outpatient colonoscopy unless patient continues with melena. He was seen by the Hematology team with no plans for inpatient systemic treatment for his underlying myelodysplastic syndrome in goals to maintain platelet above 10,000 and hemoglobin above 7, cryoprecipitate if fibrinogen is < 100 and keep fibrinogen >100. Orders also given to avoid daily blood draws and avoid all unnecessary anti-platelet and thrombocytopenia inducing medications. GU also found patient not a candidate for cystectomy regarding his muscle invasive bladder cancer and will recommend repeat cystoscopy 2 months from initial tumor resection for tumor reassessment. Palliative care was consulted at the hospital with family who agreed with DNR but did not want hospice. Dobhoff was placed for severe oropharyngeal dysphagia and encephalopathy. Patient developed a stage III sacral ulcer during his prolonged hospital stay and received wound care. He was seen by Nephrology team at the hospital secondary to acute kidney injury and electrolyte imbalance but maintained good urinary output. Patient did not require dialysis and renal function stabilized with fluids. 


Upon eval today, patient was found this morning with acute melena by nursing and is pale although his mental status is baseline and he is able to communicate that he has no current complaint.

PHYSICAL EXAM

Vital Signs

• Temperature: 99.5F

• Blood Pressure: 118/67mm Hg

• Respiratory Rate: 20/min

• Heart Rate: 80

• Pain Severity Score (0-10): 0

• Acute onset mental status change: 0


PHYSICAL EXAM

GENERAL: The patient is awake but nonverbal but able to answer yes and no questions by nodding his head he is awake and alert to himself. 

HEENT: Head atraumatic and normocephalic

Eyes: Extraocular muscles intact. Anicteric. Pupils equal, round, and reactive to light and accommodation. Nares patient. 

Mouth: Moist mucosa. 

Ears: No lesions. 

Nose: Dobhoff in place

Throat: No thrush, exudate, or erythema. 

NECK: Supple. No JVD. 

LUNGS: Breath sounds clear bilaterally without rales, rhonchi, or wheezing. 

HEART: Normal S1, S2. sinus rhythm. No appreciable gallops, rubs, murmurs or extra heart sounds. 

ABDOMEN: Obese. Soft, nontender, nondistended. Positive bowel sounds. No palpable masses or hepatosplenomegaly. 

EXTREMITIES: Weakness to bilateral upper lower 

SKIN: Stage III sacral wound. Pale

LABS X-RAY AND OTHER DATA

Lab Results

· FSBS 125 mg/dL 

· Ammonia <9 umol/L 


Blood Count;Complete w/ Auto Diff 05/17/2020

o Absolute basophils 0.2 ths/cumm

o Absolute eosinophils 0.0 ths/cumm

o Absolute lymphocytes 0.9 ths/cumm

o Absolute monocytes 0.1 ths/cumm

o Absolute neutrophils 17.0 ths/cumm

o Basophils 1 %

o Eosinophils 0 %

o Hematocrit 27.4 %

o Hemoglobin 9.4 g/dl

o Lymphocytes 4.9 %

o MCH 32.8 pg

o MCHC 34.4 %

o MCV 95.2 cu micron

o MPV 8.0 pg

o Monocytes 0.4 %

o PLT, AUTO 54 ths/cumm

o RBC, AUTO 2.9 mil/cumm

o RDW 19.0 %

o Segmented neutrophils 93.3 %

o WBC, AUTO 18.2 ths/cumm


Blood Count;Complete w/ Auto Diff 05/18/2020

Absolute basophils 0.0 ths/cumm

Absolute eosinophils 0.0 ths/cumm

Absolute lymphocytes 1.0 ths/cumm

Absolute monocytes 0.1 ths/cumm

Absolute neutrophils 6.9 ths/cumm

Basophils 0 %

Eosinophils 0 %

Hematocrit 12.8 %

Hemoglobin 4.4 g/dl

Lymphocytes 12.2 %

MCH 32.5 pg

MCHC 34.2 %

MCV 95.1 cu micron

MPV 7.9 pg

Monocytes 0.9 %

PLT, AUTO 37 ths/cumm

RBC, AUTO 1.3 mil/cumm

RDW 18.1 %

Segmented neutrophils 86.5 %

WBC, AUTO 8.0 ths/cumm


Comprehensive Metabolic Panel

o ALT 15 U/L

o AST 29 U/L

o Albumin 3.2 g/dl

o Alkaline Phosphatase 126 U/L

o Bilirubin Total 0.5 mg/dl

o Blood Urea Nitrogen 24 mg/dl

o Calcium 8.5 mg/dl

o Chloride 91 mmol/L

o Creatinine 0.50 mg/dl

o Enzymatic CO2 30 mmol/L

o GFR, African American >60.0 mL/min/1.73 sqm

o Glucose 135 mg/dl

o Potassium 3.5 mmol/L

o Protein, Total 6.5 g/dl

o Sodium 131 mmol/L


· PSA (Prostatic Spec. Ag) 2.3 ng/mL 

· PreAlbumin 18.3 mg/dL 

· Prothrombin time w/ INR

o INR 1.1

o Prothrombin time 12.7 seconds


Microscopic UA 

o Amorphous Urine LARGE

o Bacteria 3+

o Epithelial FEW

o Mucous MODERATE

o RBC 100-200 /HPF

o WBC >200 /HPF


Urinalysis 

o Appearance CLOUDY

o Bilirubin Negative

o Color YELLOW

o Glucose Negative mg/dl

o Ketone Negative mg/dL

o Leukocyte Esterase Large

o Nitrite Negative

o Occult Blood (urine) Moderate

o Protein 100 mg/dL

o Specific gravity 1.020

o Urobilinogen 1 mg/dL

o pH 7.5

MEDICATIONS

Bumetanide 1 MG daily1 Oral

Acetaminophen 650 MG PRNq6h Gastrostomy Tube

Glucose Gel 15 gm PRNq4h Gastrostomy Tube

hydrALAZINE hydrochloride 10 mg PRNq6h Intravenous

Ondansetron Hydrochloride 4 MG PRNq8h Intravenous

Insulin Lispro, Recombinant 1 EA q6h Subcutaneous Sliding Scale

Folic Acid 1 MG daily1 Gastrostomy Tube

Budesonide 0.5 MG q12h Inhalation

Lactulose 20 GM PRNdaily1 Gastrostomy Tube

Pantoprazole Sodium 40 mg

Miconazole Nitrate 2% 1 EA q shift Topical application

Metoprolol Tartrate 2.5 MG PRNq4h Intravenous

Ipratropium Bromide 0.5 MG q6h Inhalation

sulfamethoxazole/TMP 800-160MG 0.5 EA q12h Gastrostomy Tube

Sodium Chloride 0.9% at 75 cc/hour  

PROBLEM LIST

Myelodysplastic syndrome

Melana/GI bleed

Acute hypoxia respiratory failure SP intubation/extubated on 04/18 

Acute renal failure

Paroxysmal atrial fibrillation 

Multi factual encephalopathy 

Moderate motor oral pharyngeal dysphagia currently with tube feedings 

COPD tobacco use 40 pack-year history 

Type 2 diabetes 

Stage III sacral wound 

Invasive bladder cancer

Status post multifocal pneumonia 

Acute obstructive uropathy with emergency TURP  

Copyright © 2025 Hancock Medical Solutions Fort Lauderdale FL - PA Excel Solutions for PA education and educators - All Rights Reserved.

Powered by

  • Home
  • Login
  • Contact
  • About us
  • PANCE PANRE PREP
  • Live PANCE Review
  • PANCE PANRE Review team
  • Virtual Rotation
  • Clinical Rotations
  • Prepared classes
  • PA Specialists
  • Clinical Year Assistance
  • PANCE Review Testimonials
  • International Education
  • PA Student resources
  • PA Financial Planning
  • Career counseling
  • PA Program organization
  • PANCE Notes Pages
  • Free PA Student Resourses
  • HELP Campus Runthrough
  • VROD Payment Portal
  • PA Prep Academy Payment P

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept